Add-On tolterodine extended release improves overactive bladder symptoms in men receiving alpha-blocker therapy

被引：0
作者：
Chapple, C. [1 ]
Abrams, P. [2 ]
Herschorn, S. [3 ]
Sun, F. [4 ]
Brodsky, M. [5 ]
Guan, Z. [5 ]
机构：
[1] Royal Hallamshire Hosp, Dept Urol, Sheffield S10 2JF, S Yorkshire, England
[2] Bristol Urol Inst, Dept Urol, Bristol, Avon, England
[3] Univ Toronto, Dept Urol, Toronto, ON, Canada
[4] Pfizer Inc, Dept Stat, New York, NY USA
[5] Pfizer Inc, Dept Med Urol, New York, NY USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2008年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
671
引用
收藏
页码：239 / 239
页数：1
相关论文
共 50 条
[21]   Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder [J].
Kelleher, CJ ;
Reese, PR ;
Pleil, AM ;
Okano, GJ .
AMERICAN JOURNAL OF MANAGED CARE, 2002, 8 (19) :S608-S615
[22]   Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism [J].
Pessina, AC ;
Ciccariello, L ;
Perrone, F ;
Stoico, V ;
Gussoni, G ;
Scotti, A ;
Muggeo, M .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2006, 16 (02) :137-147
[23]   Persistence with solifenacin add-on therapy in men with benign prostate obstruction and residual symptoms of overactive bladder after tamsulosin monotherapy [J].
Lee, Y. -S. ;
Lee, K. -S. ;
Kim, J. C. ;
Hong, S. ;
Chung, B. H. ;
Kim, C. -S. ;
Lee, J. G. ;
Kim, D. K. ;
Park, C. H. ;
Park, J. K. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (12) :1496-1502
[24]   Zolpidem pharmacotherapy combined with alpha-blocker therapy for nocturia unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms: a preliminary study [J].
Yun Seob Song ;
Ja Hyeon Ku .
International Urology and Nephrology, 2007, 39 :1147-1152
[25]   Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Lower Urinary Tract Symptoms-ASSIST, Randomized Controlled Study [J].
Yamaguchi, Osamu ;
Kakizaki, Hidehiro ;
Homma, Yukio ;
Takeda, Masayuki ;
Nishizawa, Osamu ;
Gotoh, Momokazu ;
Yokoyama, Osamu ;
Seki, Narihito ;
Yoshida, Masaki .
UROLOGY, 2011, 78 (01) :126-133
[26]   Editorial Comment on: Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers [J].
Speakman, Mark J. .
EUROPEAN UROLOGY, 2009, 56 (03) :542-542
[27]   Zolpidem pharmacotherapy combined with alpha-blocker therapy for nocturia unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms: a preliminary study [J].
Song, Yun Seob ;
Ku, Ja Hyeon .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2007, 39 (04) :1147-1152
[28]   Effects of tolterodine extended release and/or tamsulosin on international prostate symptom scores in men with lower urinary tract symptoms including overactive bladder [J].
Roehrborn, Claus G. ;
Kaplan, Steven A. ;
Steers, William D. ;
Chancellor, Michael B. ;
Carlsson, Martin ;
Bavendam, Tamara ;
Guan, Zhonghong .
JOURNAL OF UROLOGY, 2007, 177 (04) :513-513
[29]   The Effects of Vibegron Add-on Therapy on Alpha 1-Blocker Therapy for Sexual Function and Overactive Bladder Symptoms in Benign Prostatic Hyperplasia: A Prospective, Open-Label Study [J].
Yanagida, Kazuki ;
Watanabe, Daisuke ;
Yoshida, Takahiro ;
Mizushima, Akio ;
Nakagawa, Tohru .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)
[30]   Health-related quality of life in patients with overactive bladder receiving tolterodine extended-release in Japan [J].
Homma, Y ;
Kawabe, KK .
JOURNAL OF UROLOGY, 2003, 169 (04) :345-345
12345